Active Regenerative Therapeutics

Healing
Reimagined

The first exosome-integrated wound dressing that actively orchestrates healing at the molecular level. Beyond protection — biological instruction.

R
80% Faster Closure
60% Less Scarring
100% Active Healing

The Regenex Platform

A bioactive wound dressing engineered to actively orchestrate the wound healing process. Unlike conventional dressings that act as passive barriers, Regenex functions as a regenerative therapeutic interface.

Exosome-Integrated Wound Dressing

Exosome-Lined Wound Dressing

A biocompatible, semi-permeable scaffold functionalized with therapeutic exosomes. These nanoscale extracellular vesicles serve as biological signal carriers, creating a localized microenvironment enriched with regenerative signals.

  • Exosome Layer: Controlled-density layer of purified or engineered exosomes
  • Uniform Distribution: Evenly distributed across wound-contact surface
  • Stabilized Storage: Room-temperature or refrigerated storage capability
  • Tunable Concentration: Adjustable based on clinical indication
Smart Delivery Scaffold

Smart Delivery Scaffold

Advanced biomaterial substrate providing optimal moist wound environment, gas exchange, mechanical protection, and controlled exosome release kinetics.

  • PEG Hydrogels: Biocompatible polymer matrices
  • Electrospun Nanofibers: High surface area for exosome attachment
  • Collagen Composites: Natural biomaterial scaffolds
  • Controlled Release: Gradual exosome release kinetics
Protective Barrier

Protective Outer Layer

Breathable, antimicrobial barrier that prevents infection, maintains sterility, and allows extended wear time. Ensures therapeutic exosomes remain active and protected throughout the healing process.

  • Antimicrobial Protection: Prevents bacterial infection
  • Breathable Design: Allows optimal gas exchange
  • Sterility Maintenance: Extended wear capability
  • Exosome Preservation: Maintains therapeutic activity

Active vs Passive Healing

Regenex represents a new category: off-the-shelf, cell-free regenerative therapeutics. We're turning a bandage into a localized biologics drug delivery device.

01
Cell-Free Regenerative Therapy
Avoids risks of live cell therapies: no immune rejection, no tumorigenicity, easier regulatory pathway, and longer shelf life. Pure biological signaling without cellular complexity.
02
Localized Precision Delivery
High local therapeutic concentration with minimal systemic exposure. Reduced off-target effects through direct wound-site application of regenerative signals.
03
Biological Instruction Layer
Unlike traditional dressings that only protect, Regenex actively modulates the four canonical phases of wound healing through exosomal molecular signaling.
04
Clinical & Commercial Viability
Positioned at the intersection of regenerative medicine, biomaterials, and biologics delivery. Scalable, clinically deployable, and transformative for patient outcomes.

How Exosomes
Heal Wounds

Exosomes act as natural intercellular communication vehicles. Scroll to explore the molecular healing network.

Phase 01
Hemostasis
Platelets aggregate at the wound site, forming a protective clot. Exosomes released from platelets and nearby stem cells attach to the clot, releasing signals that stabilize the barrier and prepare the scaffold for repair.
Clot formation
Phase 02
Inflammation
Pro-inflammatory M1 macrophages arrive to clear pathogens. Exosomes attach to these immune cells, shifting them from “attack” mode M1 to reparative M2 phenotype — reducing excessive inflammation and initiating the repair cascade.
Immune modulation
Phase 03
Proliferation
Exosomes stimulate fibroblasts to produce collagen fibers, promote endothelial cells to form new capillaries, and drive keratinocyte migration across the wound surface — accelerating tissue rebuilding.
Tissue rebuilding
Phase 04
Remodeling
Exosomes guide the replacement of disorganized collagen with stronger, aligned fibers. Excess cells and vessels gracefully recede, leaving mature, resilient tissue with minimal scarring.
Tissue maturation
Scroll to explore
1
Hemostasis
Exosomes initiate blood clotting and prepare the scaffold for repair. Platelet-derived and stem cell-derived exosomes stabilize the clot barrier and tighten blood vessels at the wound site.
2
Inflammation
Exosomes shift immune cells from attack mode to repair mode. M1 macrophages polarize toward the reparative M2 phenotype, reducing excessive inflammation and releasing growth factors.
3
Proliferation
Exosomes speed up cell migration, collagen production, and new blood vessel formation. Fibroblasts, endothelial cells, and keratinocytes rebuild tissue architecture.
4
Remodeling
Exosomes ensure proper collagen alignment and reduce scar formation. Disorganized Type III collagen is replaced with stronger Type I collagen, restoring skin strength.

Clinical Impact

Transforming wound care outcomes through active regenerative intervention.

80%
Faster Closure
vs. standard dressings
(Zhang et al., 2023)
60%
Reduced Scarring
hypertrophic scar reduction
(Chen et al., 2022)
70%
Better Outcomes
functional recovery improvement
(Li et al., 2023)
100%
Active Healing
biologically active exosomes
(Regenex Research, 2024)

Target Indications

Addressing the most challenging wound healing scenarios with precision regenerative therapy.

Chronic Diabetic Ulcers
Non-healing wounds that require active regenerative intervention to overcome impaired healing mechanisms and chronic inflammatory states.
Pressure Ulcers
Bed sores and pressure-induced wounds benefiting from accelerated tissue repair and enhanced angiogenesis.
Surgical Wounds
Post-surgical incisions requiring faster closure rates, reduced complications, and improved aesthetic outcomes.
Burn Injuries
Promoting faster re-epithelialization and reducing scarring in burn wound management through enhanced matrix remodeling.
Trauma & Emergency
Acute trauma cases requiring immediate healing response and rapid tissue regeneration for optimal recovery.
Cosmetic Dermatology
Post-procedural recovery and advanced skin repair through targeted exosome delivery systems for aesthetic applications.

About Regenex

Pioneering the next generation of regenerative therapeutics at the intersection of regenerative medicine, biomaterials, and biologics delivery.

Our Mission

To accelerate healing and transform patient outcomes through advanced regenerative medicine technologies that work in harmony with the body's natural healing processes.

Our Vision

A future where complex wounds heal faster with better outcomes, where regenerative medicine is the standard of care, and every patient has access to next-generation healing technologies.

Our Approach

We integrate engineered exosomes into practical, clinically deployable products that deliver active regenerative signals directly to the wound site.